In conclusion, further studies are required to utilize in vivo mice model or clinical samples but not breast cancer cell lines alone to elucidate the importance of VGCCs/TRPs/SOCE in luminal and Her2+ subtypes in the context of bone metastasis. This evidence concerns the gene ERBB2 and breast carcinoma.